ArticleJournal of translational medicine2023

Chimeric antigen receptor T cells targeting cell surface GRP78 efficiently kill glioblastoma and cancer stem cells.

Shijie Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.